| Mechanisms of antibiotic resistance. Microbiol Spectr. 2016; 4 JM Munita, CA Arias VMBF-0016-2015, 0 | 3179* | |
| Mechanisms of antibiotic resistance in enterococci WR Miller, JM Munita, CA Arias Expert review of anti-infective therapy 12 (10), 1221-1236, 2014 | 789 | 2014 |
| Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples L Porte, P Legarraga, V Vollrath, X Aguilera, JM Munita, R Araos, ... International Journal of Infectious Diseases 99, 328-333, 2020 | 446 | 2020 |
| Mechanisms of drug resistance: daptomycin resistance TT Tran, JM Munita, CA Arias Annals of the New York Academy of Sciences 1354 (1), 32-53, 2015 | 266 | 2015 |
| Transferable vancomycin resistance in a community-associated MRSA lineage F Rossi, L Diaz, A Wollam, D Panesso, Y Zhou, S Rincon, A Narechania, ... New England Journal of Medicine 370 (16), 1524-1531, 2014 | 226 | 2014 |
| Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids TT Tran, D Panesso, NN Mishra, E Mileykovskaya, Z Guan, JM Munita, ... MBio 4 (4), e00281-13, 2013 | 195 | 2013 |
| Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs L Diaz, TT Tran, JM Munita, WR Miller, S Rincon, LP Carvajal, A Wollam, ... Antimicrobial agents and chemotherapy 58 (8), 4527-4534, 2014 | 163 | 2014 |
| Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective … M Wang, M Earley, L Chen, BM Hanson, Y Yu, Z Liu, S Salcedo, E Cober, ... The Lancet Infectious Diseases 22 (3), 401-412, 2022 | 149 | 2022 |
| Evolving resistance among Gram-positive pathogens JM Munita, AS Bayer, CA Arias Clinical Infectious Diseases 61 (suppl_2), S48-S57, 2015 | 146 | 2015 |
| Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa JM Munita, SL Aitken, WR Miller, F Perez, R Rosa, LA Shimose, ... Clinical Infectious Diseases 65 (1), 158-161, 2017 | 141 | 2017 |
| A prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine Latin American countries CA Arias, J Reyes, LP Carvajal, S Rincon, L Diaz, D Panesso, G Ibarra, ... Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 00816-17, 2017 | 136 | 2017 |
| Whole-genome analysis of a daptomycin-susceptible Enterococcus faecium strain and its daptomycin-resistant variant arising during therapy TT Tran, D Panesso, H Gao, JH Roh, JM Munita, J Reyes, L Diaz, ... Antimicrobial agents and chemotherapy 57 (1), 261-268, 2013 | 130 | 2013 |
| Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints JM Munita, D Panesso, L Diaz, TT Tran, J Reyes, A Wanger, BE Murray, ... Antimicrobial agents and chemotherapy 56 (8), 4354-4359, 2012 | 127 | 2012 |
| Mechanisms of antibiotic resistance. Microbiol. Spectr. 2016; 4 doi: 10.1128/microbiolspec JM Munita, CA Arias VMBF-0016-2015.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 113 | |
| A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis J Reyes, D Panesso, TT Tran, NN Mishra, MR Cruz, JM Munita, KV Singh, ... The Journal of infectious diseases 211 (8), 1317-1325, 2015 | 107 | 2015 |
| Resistance to" last resort" antibiotics in Gram-positive cocci: The post-vancomycin era S Rincón, D Panesso, L Díaz, LP Carvajal, J Reyes, JM Munita, CA Arias Biomedica 34, 191-208, 2014 | 106* | 2014 |
| The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia WR Miller, C Seas, LP Carvajal, L Diaz, AM Echeverri, C Ferro, R Rios, ... Open forum infectious diseases 5 (6), ofy123, 2018 | 98 | 2018 |
| Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? ACA Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J ... Clinical Infectious Diseases, 2016 | 98 | 2016 |
| A liaF Codon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant Enterococcus faecalis JM Munita, TT Tran, L Diaz, D Panesso, J Reyes, BE Murray, CA Arias Antimicrobial agents and chemotherapy 57 (6), 2831-2833, 2013 | 79 | 2013 |
| Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study J Reyes, L Komarow, L Chen, L Ge, BM Hanson, E Cober, E Herc, ... The Lancet Microbe 4 (3), e159-e170, 2023 | 77 | 2023 |
Rafael AraosFacultad de Medicina Clinica Alemana, Universidad del Desarrollo, Chile在 udd.cl 的电子邮件经过验证
